Cytokines may be involved in depression pathogenesis by regulating monoamine neurotransmitter metabolism and influencing neuroendocrine function (27), therefore, TNF-α, and IL-6 levels may serve as quantitative indicators of MDD patients in their early stages and as objective biomarkers for the disease. The gene discussed is IL6; the disease is depressive symptom measurement.